Clinical and Radiographic Predictors of Progression and Survival in Relapsed/Refractory Lymphoma Patients Receiving Anti-CD19 CAR T-cell Therapy.

Jodon, Gray; Colton, Meryl D; Abbott, Diana; Cai, Anthony; Haverkos, Bradley; Morgan, Rustain; Kamdar, Manali

Jodon, Gray; Colton, Meryl D; Abbott, Diana; Cai, Anthony; Haverkos, Bradley; Morgan, Rustain; Kamdar, Manali.

Afiliação

Jodon G; Division of Hematology, Hematologic Malignancies and Stem Cell Transplantation, University of Colorado Cancer Center, Aurora, CO. Electronic address: gray.jodon@cuanschutz.edu.
Colton MD; Department of Internal Medicine, University of Colorado School of Medicine, Aurora, CO.
Abbott D; Center for Innovative Design and Analysis, Department of Biostatistics and Informatics, University of Colorado School of Public Health, CO.
Cai A; Department of Radiology, University of Colorado School of Medicine, Aurora, CO.
Haverkos B; Division of Hematology, Hematologic Malignancies and Stem Cell Transplantation, University of Colorado Cancer Center, Aurora, CO.
Morgan R; Department of Radiology, University of Colorado School of Medicine, Aurora, CO.
Kamdar M; Division of Hematology, Hematologic Malignancies and Stem Cell Transplantation, University of Colorado Cancer Center, Aurora, CO.

Clin Lymphoma Myeloma Leuk ; 23(1): 49-56, 2023 01.

Article em En | MEDLINE | ID: mdl-36335021

Assuntos

Linfoma de Células B; Linfoma; Humanos; Imunoterapia Adotiva/efeitos adversos; Recidiva Local de Neoplasia/terapia; Antígenos CD19

Palavras-chave

Non-Hodgkin's lymphoma; adoptive cellular therapy; model; prediction; prognostic

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Linfoma de Células B / Linfoma Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Clin Lymphoma Myeloma Leuk Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google